Investing Ideas
/
Australian Pharmaceuticals & Biotech Dollar's Gain Retailers' Pain

Header cover image

Australian Pharmaceuticals & Biotech Dollar's Gain Retailers' Pain

UPDATED May 04, 2024

Strengthening dollar is a drag on the tourism industry and exports putting pressure on apparel and shoe retailers.

10 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	PYC PYC Therapeutics	AU$0.10	14.1%	72.1%	AU$489.9m	n/a	PS23.1x	E37.8%	n/a
	CU6 Clarity Pharmaceuticals	AU$3.65	44.3%	386.7%	AU$1.1b	AU$3.41	PS119.6x	E34.1%	n/a
	NEU Neuren Pharmaceuticals	AU$19.70	5.6%	40.7%	AU$2.5b	AU$26.74	PE16x	E5.2%	n/a
	IMU Imugene	AU$0.082	3.8%	-31.7%	AU$600.2m	n/a	PS39.9x	E51.9%	n/a
	IMM Immutep	AU$0.43	3.6%	70.6%	AU$517.1m	n/a	PS131.6x	E20.0%	n/a
	MSB Mesoblast	AU$1.09	16.7%	11.9%	AU$1.2b	AU$1.10	PS109.6x	E56.8%	n/a
	CUV Clinuvel Pharmaceuticals	AU$14.86	2.0%	-23.9%	AU$744.5m	AU$25.60	PE24.7x	E12.9%	0.3%
	CSL CSL	AU$275.80	0.9%	-8.4%	AU$133.3b	AU$306.40	PE35.6x	E14.7%	1.3%
	MYX Mayne Pharma Group	AU$7.37	6.3%	75.5%	AU$598.1m	AU$7.04	PS1.9x	E110.2%	n/a
	TLX Telix Pharmaceuticals	AU$15.24	2.2%	39.3%	AU$5.0b	AU$15.29	PE966.4x	E36.2%	n/a

Page 1 of 1